跳至主要内容
临床试验/NCT04600258
NCT04600258已完成不适用

Chocolate for the Patient With Chronic Kidney Disease: a New Strategy to Modulate Inflammation?

Universidade Federal Fluminense3 个研究点 分布在 1 个国家目标入组 59 人开始时间: 2020年10月30日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
59
试验地点
3
主要终点
Inflammatory biomarkers

研究概览

简要总结

Chocolate is a widely appreciated foodstuff with historical appreciation as food from the gods. It is a rich source of (poly)phenolics, which have several proposed salutogenic effects, including neuroprotective anti-inflammatory, antioxidant, and cardioprotective properties.

This study will evaluate the potential salutogenic contribution of chocolate intake, to mitigate inflammatory and oxidative burden in chronic kidney disease patients.

详细描述

This study is evaluating patients with CKD on a regular HD program randomized in the chocolate group and control group. The chocolate group is receiving 40g of dark chocolate per day for 2 months and the control group is not receiving any intervention. Peripheral blood mononuclear cells (PBMC) are being isolated for expression of Nrf2, NF-kB, and NADPH quinone oxidoreductase 1 (NQO1) by a quantitative real-time polymerase chain reaction. Antioxidant enzymes activity (catalase-CAT and glutathione peroxidase-GPx), high-sensitivity C-reactive protein (hs-CRP) will be assessed using an enzyme-linked immunosorbent assay (ELISA).

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Health Services Research
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

盲法说明

Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Clinical diagnosis of Chronic Kidney Disease
  • Hemodialysis patients for more than 6 months
  • Aged 18 years or older

排除标准

  • Patients pregnant
  • Using antibiotics in the last 3 months
  • Autoimmune diseases
  • Clinical diagnosis of infectious diseases
  • Clinical diagnosis of Cancer
  • Clinical diagnosis of AIDS

研究组 & 干预措施

Control Group

No Intervention

No intervention and analysis will be performed before and after 2 months

结局指标

主要结局

Inflammatory biomarkers

时间窗: 2 months

Get blood samples to evaluate the supplementation effects in inflammatory biomarkers- factor nuclear kappa B (NFkB), interleukin 6 (IL-6), tumor necrosis factor alpha (TNF-alpha)

Antioxidants and anti-inflammatory biomarkers

时间窗: 2 months

Get blood samples to evaluate the supplementation effects in antioxidants biomarkers- nuclear receptor factor 2 (Nrf2), glutathioneperoxidase (GPx), heme oxygenase-1 (HO-1)

次要结局

  • Uremic toxins(2 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Denise Mafra

Full Professor

Universidade Federal Fluminense

研究点 (3)

Loading locations...

相似试验